Table 2 Serum lipids level of patients according to the expression status of estrogen receptor (ER) and progesterone receptor (PR)
From: The association between serum lipid levels and histological type of breast cancer
Variables | ER expression status | PR expression status | ||||
|---|---|---|---|---|---|---|
ER-BC (N = 70) | ER + BC (N = 150) | P | PR-BC (N = 73) | PR + BC (N = 144) | P | |
HDL-c (mmol/L) | 70 | 150 | 0.02 | 73 | 144 | 0.28 |
 ≤ 1.36 | 16 (22.9%) | 58 (38.7%) | 21 (28.8%) | 52 (36.1%) | ||
 > 1.36 | 54 (77.1%) | 92 (61.3%) | 52 (71.2%) | 92 (63.9%) | ||
LDL-c (mmol/L) | 70 | 150 | 0.03 | 73 | 144 |  < 0.01 |
 ≤ 2.08 | 5 (7.1%) | 28 (18.7%) | 4 (5.5%) | 29 (20.1%) | ||
 > 2.08 | 65 (92.9%) | 122 (81.3%) | 69 (94.5%) | 115 (79.9%) | ||
TC(mmol/L) | 70 | 150 | 0.24 | 73 | 144 | 0.36 |
 ≤ 5.12 | 48 (68.6%) | 114 (76.0%) | 51 (69.9%) | 109 (75.7%) | ||
 > 5.12 | 22 (31.4%) | 36 (24.0%) | 22 (30.1%) | 35 (24.3%) | ||
TG(mmol/L) | 70 | 150 | 0.09 | 73 | 144 | 0.30 |
 ≤ 1.52 | 57 (81.4%) | 106 (70.7%) | 57 (78.1%) | 103 (71.5%) | ||
 > 1.52 | 13 (18.6%) | 44 (29.3%) | 16 (21.9%) | 41 (28.5%) | ||
ApoA(g/L) | 70 | 150 | 0.28 | 73 | 144 | 0.61 |
 ≤ 1.34 | 39 (55.7%) | 95 (63.3%) | 43 (58.9%) | 90 (62.5%) | ||
 > 1.34 | 31(44.3%) | 55 (36.7%) | 30 (41.1%) | 54 (37.5%) | ||
ApoB(g/L) | 70 | 150 | 0.15 | 73 | 144 | 0.08 |
 ≤ 0.76 | 17 (24.3%) | 51 (34%) | 17 (23.3%) | 50 (34.7%) | ||
 > 0.76 | 53 (75.7%) | 99 (66%) | 56 (76.7%) | 94 (65.3%) | ||
ApoE(mg/dL) | 70 | 150 | 0.17 | 73 | 144 | 0.71 |
 ≤ 4.7 | 47 (67.1%) | 114 (76.0%) | 52 (71.2%) | 106 (73.6%) | ||
 > 4.7 | 23 (32.9%) | 36 (24.0%) | 21 (28.8%) | 38 (26.4%) | ||
LP(a) (mg/L) | 70 | 150 | 0.02 | 73 | 144 | 0.01 |
 ≤ 33 | 11 (15.7%) | 45 (30%) | 11 (15.1%) | 44 (30.6%) | ||
 > 33 | 59 (84.3%) | 105 (70%) | 62 (84.9%) | 100 (69.4%) | ||
HDL/TC | 70 | 150 | 0.25 | 73 | 144 | 0.56 |
 ≤ 0.29 | 18 (25.7%) | 50 (33.3%) | 21 (28.8%) | 47 (32.6%) | ||
 > 0.29 | 52 (74.3%) | 100 (66.7%) | 52 (71.2%) | 97 (67.4%) | ||
LDL/TC | 70 | 150 | 0.21 | 73 | 144 | 0.04 |
 ≤ 0.64 | 42 (60.0%) | 103 (68.7%) | 41 (56.2%) | 101 (70.1%) | ||
 > 0.64 | 28 (40.0%) | 47 (31.3%) | 32 (43.8%) | 43 (29.9%) | ||
ApoA/ApoB | 70 | 150 | 0.62 | 73 | 144 | 0.87 |
 ≤ 1.22 | 19 (27.1%) | 36 (24%) | 19 (26.0%) | 36 (25%) | ||
 > 1.22 | 51 (72.9%) | 114 (76%) | 54 (74.0%) | 108 (75%) | ||
HDL/ApoA (mmol/g) | 70 | 150 | 0.25 | 73 | 144 | 0.24 |
 ≤ 1.09 | 21 (30%) | 57 (38%) | 22 (30.1%) | 55 (38.2%) | ||
 > 1.09 | 49 (70%) | 93 (62%) | 51 (69.9%) | 89 (61.8%) | ||
LDL/ApoB | 70 | 150 | 0.16 | 73 | 144 | 0.04 |
(mmol/g) | 11 (15.7%) | 14 (9.3%) | 13 (17.8%) | 12 (8.3%) | ||
 ≤ 2.66 | 59 (84.3%) | 136 (90.7%) | 60 (82.2%) | 132 (91.7%) | ||